BIOFILCHEM
Invest Now
Start SIP in
BIOFILCHEM
Performance
- Low
- ₹46
- High
- ₹48
- 52 Week Low
- ₹40
- 52 Week High
- ₹92
- Open Price₹48
- Previous Close₹46
- Volume4,659
Investment Returns
- Over 1 Month -7.16%
- Over 3 Month + 7.9%
- Over 6 Month -13.35%
- Over 1 Year -29.02%
Smart Investing Starts Here Start SIP with Biofil Chemicals & Pharmaceuticals for Steady Growth!
Biofil Chemicals & Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 135.8
- PEG Ratio
- -6.4
- Market Cap Cr
- 76
- P/B Ratio
- 4
- Average True Range
- 2.08
- EPS
- 0.34
- Dividend Yield
- 0
- MACD Signal
- -0.42
- RSI
- 46.06
- MFI
- 48.76
Biofil Chemicals & Pharmaceuticals Financials
Biofil Chemicals & Pharmaceuticals Technicals
EMA & SMA
Current Price
₹46.55
+
0.19
(0.41%)

-
- Bearish Moving Average 13
-
- Bullish Moving Average 3
- 20 Day
- ₹47.08
- 50 Day
- ₹47.38
- 100 Day
- ₹48.69
- 200 Day
- ₹52.27
Resistance and Support
46.84
- R3 49.45
- R2 48.68
- R1 47.61
- S1 45.77
- S2 45.00
- S3 43.93
Biofil Chemicals & Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-05-30 | Audited Results | |
2025-02-11 | Quarterly Results & Others | To consider other business matters. |
2024-11-14 | Quarterly Results | |
2024-08-13 | Quarterly Results | |
2024-05-30 | Audited Results |
Biofil Chemicals & Pharmaceuticals F&O
About Biofil Chemicals & Pharmaceuticals
- NSE Symbol
- BIOFILCHEM
- BSE Symbol
- 524396
- Chairman & Managing Director
- Mr. Ramesh Shah
- ISIN
- INE829A01014
Similar Stocks to Biofil Chemicals & Pharmaceuticals
Biofil Chemicals & Pharmaceuticals FAQs
Biofil Chemicals & Pharmaceuticals share price is ₹46 As on 16 July, 2025 | 04:27
The Market Cap of Biofil Chemicals & Pharmaceuticals is ₹75.8 Cr As on 16 July, 2025 | 04:27
The P/E ratio of Biofil Chemicals & Pharmaceuticals is 135.8 As on 16 July, 2025 | 04:27
The PB ratio of Biofil Chemicals & Pharmaceuticals is 4 As on 16 July, 2025 | 04:27
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.